N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119

Molecular Endocrinology

Volumn 24, Issue 1, 2010, Pages 161-170

  Chu, Zhi Liang ^a   Carroll, Chris ^a   Chen, Ruoping ^a   Alfonso, Jean ^a   Gutierrez, Veronica ^a   He, Hongmei ^a   Lucman, Annette ^a   Xing, Charles ^a   Sebring, Kristen ^a   Zhou, Jinyao ^a   Wagner, Brandee ^a   Unett, David ^a   Jones, Robert M ^a   Behan, Dominic P ^a   Leonard, James ^a  

^a ARENA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CYCLIC AMP; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; LIPID; N OLEOYLDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; GENETIC TRANSFECTION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMIDES; ANIMALS; BLOOD GLUCOSE; CELL LINE; CRICETINAE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; ORGAN SPECIFICITY; RATS; RECEPTORS, G-PROTEIN-COUPLED;

MUS;

EID: 73549104997     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0239     Document Type: Article

References (44)

1. Chu ZL, Jones RM, He H, Carroll C, Gutierrez V, Lucman A, Moloney M, Gao H, Mondala H, Bagnol D, Unett D, Liang Y, Demarest K, Semple G, Behan DP, Leonard J 2007 A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 148: 2601-2609
2. Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D, Chen R, Jones RM, Behan DP, Leonard J 2008 A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulino-tropic peptide release. Endocrinology 149:2038-2047
3. Lauffer LM, Iakoubov R, Brubaker PL 2009 GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58:1058-1066
4. Semple G, Fioravanti B, Pereira G, Calderon I, Uy J, Choi K, Xiong Y, Ren A, Morgan M, Dave V, Thomsen W, Unett DJ, Xing C, Bossie S, Carroll C, Chu ZL, Grottick AJ, Hauser EK, Leonard J, Jones RM 2008 Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. J Med Chem 51:5172-5175
5. Bonini J, Borowsky B, Adham N, Boyle N, Thompson T 2002 Methods of identifying compounds that bind to SNORF25 receptors. U.S. Patent No. 6468756
6. Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, Jackson HC, Procter MJ, Rasamison CM, Tang-Christensen M, Widdowson PS, Williams GM, Reynet C 2006 Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167-175
7. Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, Matsumoto S, Kamohara M, Hiyama H, Yoshida S, Momose K, Ueda Y, Matsushime H, Kobori M, Furuichi K 2005 Lysophos-phatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751
8. Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, Piomelli D 2007 Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282:1518-1528
9. Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, Abbondanzo SJ, Hu W, Yang S, Ning Y, Del Vecchio RA, Poulet F, Laverty M, Gustafson EL, Hedrick JA, Kowalski TJ 2009 GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol 201:219-230
10. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D 2003 Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 425:90-93
11. Chu CJ, Huang SM, De Petrocellis L, Bisogno T, Ewing SA, Miller JD, Zipkin RE, Daddario N, Appendino G, Di Marzo V, Walker JM 2003 N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia. J Biol Chem 278:13633-13639
12. De Petrocellis L, Chu CJ, Moriello AS, Kellner JC, Walker JM, Di Marzo V 2004 Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br J Pharmacol 143:251-256
13. Ahern GP 2003 Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278:30429-30434
14. Suardíaz M, Estivill-Torrús G, Goicoechea C, Bilbao A, Rodríguez de Fonseca F 2007 Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. Pain 133:99-110
15. Pacher P, Bátkai S, Kunos G 2006 The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58: 389-462
16. Eisenhofer G, Aneman A, Friberg P, Hooper D, Fåndriks L, Lonroth H, Hunyady B, Mezey E 1997 Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864-3871
17. Eldrup E, Moller SE, Andreasen J, Christensen NJ 1997 Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid. Clin Sci (Lond) 92:423-430
18. Eldrup E, Richter EA 2000 DOPA, dopamine, and DOPAC concentrations in the rat gastrointestinal tract decrease during fasting. Am J Physiol Endocrinol Metab 279:E815-E822
19. Ortar G, Ligresti A, De Petrocellis L., Morera E, Di Marzo V 2003 Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65:1473-1481.
20. de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V 2004 In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. Eur J Pharmacol 484:249-257
21. Potenza MN, Graminski GF, Lerner MR 1992 A method for evaluating the effects of ligands upon Gs protein-coupled receptors using a recombinant melanophore-based bioassay. Anal Biochem 206:315-322
22. Leggett JD, Aspley S, Beckett SR, D'Antona AM, Kendall DA, Kendall DA 2004 Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 141: 253-262
23. Akiba Y, Kato S, Katsube K, Nakamura M, Takeuchi K, Ishii H, Hibi T 2004 Transient receptor potential vanilloid subfamily 1 expressed in pancreatic islet β cells modulates insulin secretion in rats. Biochem Biophys Res Commun 321:219-225
24. Appendino G, Daddario N, Minassi A, Moriello AS, De Petrocellis L, Di Marzo, V 2005 The taming of capsaicin. Reversal of the vanilloid activity of N-acylvanillamines by aromatic iodination. J Med Chem 48:4663-4669
25. Ning Y, O'Neill K, Lan H, Pang L, Shan LX, Hawes BE, Hedrick JA 2008 Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 155:1056-1065
26. Hu SS, Bradshaw HB, Benton VM, Chen JS, Huang SM, Minassi A, Bisogno T, Masuda K, Tan B, Roskoski Jr R, Cravatt BF, Di Marzo, V, Walker JM 2009 The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine. Prostaglandins Leukot Essent Fatty Acids 89:291-301
27. De Petrocellis L, Marini P, Matias I, Moriello AS, Starowicz K, Cristino L, Nigam S, Di Marzo, V 2007 Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma β-cells. Exp Cell Res 313:2993-3004
28. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V 2002 An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99:8400-8405
29. Mueller GP, Driscoll WJ 2007 In vitro synthesis of oleoylglycine by cytochrome c points to a novel pathway for the production of lipid signaling molecules. J Biol Chem 282:22364-22369
30. McCue JM, Driscoll WJ, Mueller GP 2008 Cytochrome c catalyzes the in vitro synthesis of arachidonoyl glycine. Biochem Biophys Res Commun 365:322-327
31. Teitelman G, Alpert S, Polak JM, Martinez A, Hanahan D 1993 Precursor cells of mouse endocrine pancreas coexpress insulin, glucagon and the neuronal proteins tyrosine hydroxylase and neuropeptide Y, but not pancreatic polypeptide. Development 118: 1031-1039
32. Iturriza FC, Thibault J 1993 Immunohistochemical investigation of tyrosine-hydroxylase in the islets of Langerhans of adult mice, rats and guinea pigs. Neuroendocrinology 57:476-480
33. Rorsman F, Husebye ES, Winqvist O, Björk E, Karlsson FA, Kämpe O 1995 Aromatic-L-amino-acid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a β-cell autoantigen. Proc Natl Acad Sci USA 92:8626-8629
34. Borelli MI, Villar MJ, Orezzoli A, Gagliardino JJ 1997 Presence of DOPA decarboxylase and its localisation in adult rat pancreatic islet cells. Diabetes Metab 23:161-163
35. Borelli MI, Rubio M, García ME, Flores LE, Gagliardino JJ 2003 Tyrosine hydroxylase activity in the endocrine pancreas: changes induced by short-term dietary manipulation. BMC Endocr Disord 3:2
36. Persson-Sjögren S, Forsgren S, Shi CL, Täljedal IB 2001 Mouse islets cultured with vasoactive intestinal polypeptide: effects on insulin release and immunoreactivity for tyrosine hydroxylase. Pancreas 22:84-90
37. Cegrell L 1968 The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Physiol Scand Suppl 314: 1-60
38. Lundquist I, Ahrén B, Hansson C, Håkanson R 1989 Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography. Pancreas 4:662-667
39. Starowicz KM, Cristino L, Matias I, Capasso R, Racioppi A, Izzo AA, Di Marzo, V 2008 Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16:553-565
40. Tharp WG, Lee YH, Maple RL, Pratley RE 2008 The cannabinoid CB1 receptor is expressed in pancreatic δ-cells. Biochem Biophys Res Commun 372:595-600
41. Arreaza G, Devane WA, Omeir RL, Sajnani G, Kunz J, Cravatt BF, Deutsch DG 1997 The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine. Neurosci Lett 234:59-62
42. Maurelli S, Bisogno T, De Petrocellis L, Di Luccia A, Marino G, Di Marzo, V 1995 Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma "anandamide amidohydrolase." FEBS Lett 377:82-86
43. Ho WS, Barrett DA, Randall MD 2008 "Entourage" effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br J Pharmacol 155:837-846
44. Almási R, Szoke E, Bölcskei K, Varga A, Riedl Z, Sándor Z, Szolcsányi J, Petho G 2008 Actions of 3-methyl-N-oleoyldopamine, 4-methyl-N-oleoyldopamine and N-oleoylethanolamide on the rat TRPV1 receptor in vitro and in vivo. Life Sci 82:644-651